MiR-542-3p Suppresses Neuroblastoma Cell Proliferation and Invasion by Downregulation of KDM1A and ZNF346

Overview

Journal Open Life Sci

Specialty Biology

Date 2021 May 14

PMID 33987474

Citations 5

Authors

Qiang Wei

Zhao Guo

Dong Chen

Xinjian Jia

Affiliations

Soon will be listed here.

Abstract

Neuroblastoma is one of the most common malignancies in infants and children. MicroRNAs (miRNAs) have been reported as significant regulators that play important roles in neuroblastoma development. This research aimed to analyze the functional mechanism of miR-542-3p in neuroblastoma. Here, we found that miR-542-3p was downregulated and KDM1A as well as ZNF346 were upregulated in neuroblastoma tissues and cells. Both overexpression of miR-542-3p and the knockdown of KDM1A suppressed cell proliferation and invasion in neuroblastomas. Moreover, miR-542-3p reduced the levels of KDM1A and ZNF346 through interaction. Both KDM1A overexpression and ZNF346 upregulation weakened the effect of miR-542-3p on neuroblastoma cells. Besides, miR-542-3p negatively regulated tumor growth . Our results suggested that miR-542-3p suppressed cell proliferation and invasion by targeting KDM1A and ZNF346 in neuroblastomas, providing a theoretical basis for the treatment of neuroblastoma.

Citing Articles

MicroRNA-542-3p targets Pten to inhibit the myoblasts proliferation but suppresses myogenic differentiation independent of targeted Pten.

Li D, Yue Y, Feng X, Lv W, Fan Y, Sha P BMC Genomics. 2024; 25(1):325.

PMID: 38561670 PMC: 10983626. DOI: 10.1186/s12864-024-10260-y.

Role of non-coding RNAs in neuroblastoma.

Anoushirvani A, Jafarian Yazdi A, Amirabadi S, Ahmadi Asouri S, Shafabakhsh R, Sheida A Cancer Gene Ther. 2023; 30(9):1190-1208.

PMID: 37217790 DOI: 10.1038/s41417-023-00623-0.

CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p.

Zhao L, Fan J, Zhang C, Zhang Z, Dong J Open Med (Wars). 2023; 18(1):20230672.

PMID: 36941992 PMC: 10024347. DOI: 10.1515/med-2023-0672.

and Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma.

Peng Q, Li J, Wu Q, Wang P, Kang Z, Deng Y Int J Mol Sci. 2023; 24(4).

PMID: 36834567 PMC: 9962939. DOI: 10.3390/ijms24043155.

Role and Dysregulation of miRNA in Patients with Parkinson's Disease.

Salemi M, Marchese G, Lanza G, Cosentino F, Salluzzo M, Schillaci F Int J Mol Sci. 2023; 24(1).

PMID: 36614153 PMC: 9820759. DOI: 10.3390/ijms24010712.

References

Yang C, Wang M, Zhou J, Chi Q . Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling. Oncol Rep. 2017; 38(6):3545-3553. DOI: 10.3892/or.2017.6054. View

Wu T, Lin Y, Xie Z . MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma. Biol Res. 2018; 51(1):13. PMC: 5966945. DOI: 10.1186/s40659-018-0162-y. View

Ambrosio S, Majello B . Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases. J Exp Neurosci. 2018; 12:1179069518765743. PMC: 5863861. DOI: 10.1177/1179069518765743. View

Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, Binda C . A novel mammalian flavin-dependent histone demethylase. J Biol Chem. 2009; 284(26):17775-82. PMC: 2719416. DOI: 10.1074/jbc.M109.003087. View

Bennani-Baiti I, Machado I, Llombart-Bosch A, Kovar H . Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum Pathol. 2012; 43(8):1300-7. DOI: 10.1016/j.humpath.2011.10.010. View

Yang H, Li Q, Zhao W, Yuan D, Zhao H, Zhou Y . miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. FEBS Lett. 2013; 588(1):192-7. DOI: 10.1016/j.febslet.2013.11.036. View

Liu X, Peng H, Liao W, Luo A, Cai M, He J . MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1. Mol Carcinog. 2018; 57(9):1237-1250. DOI: 10.1002/mc.22839. View

Liu B, Li J, Cairns M . Identifying miRNAs, targets and functions. Brief Bioinform. 2012; 15(1):1-19. PMC: 3896928. DOI: 10.1093/bib/bbs075. View

Brodeur G . Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003; 3(3):203-16. DOI: 10.1038/nrc1014. View

10.

Maris J, Hogarty M, Bagatell R, Cohn S . Neuroblastoma. Lancet. 2007; 369(9579):2106-20. DOI: 10.1016/S0140-6736(07)60983-0. View

11.

Ismail T, Lee H, Kim C, Kwon T, Park T, Lee H . KDM1A microenvironment, its oncogenic potential, and therapeutic significance. Epigenetics Chromatin. 2018; 11(1):33. PMC: 6006565. DOI: 10.1186/s13072-018-0203-3. View

12.

Bray I, Tivnan A, Bryan K, Foley N, Watters K, Tracey L . MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. Cancer Lett. 2011; 303(1):56-64. PMC: 3057396. DOI: 10.1016/j.canlet.2011.01.016. View

13.

Rang Z, Yang G, Wang Y, Cui F . miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma. Biochem Biophys Res Commun. 2016; 474(2):315-320. DOI: 10.1016/j.bbrc.2016.04.093. View

14.

Mueller S, Matthay K . Neuroblastoma: biology and staging. Curr Oncol Rep. 2009; 11(6):431-8. DOI: 10.1007/s11912-009-0059-6. View

15.

Sharp S, Gelfand M, Shulkin B . Pediatrics: diagnosis of neuroblastoma. Semin Nucl Med. 2011; 41(5):345-53. DOI: 10.1053/j.semnuclmed.2011.05.001. View

16.

OReilly J, Fitzgerald J, Fitzgerald S, Kenny D, Kay E, OKennedy R . Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer. PLoS One. 2015; 10(4):e0123469. PMC: 4395473. DOI: 10.1371/journal.pone.0123469. View

17.

Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch L, Holler T . H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1. Hum Pathol. 2009; 41(2):181-9. DOI: 10.1016/j.humpath.2009.08.007. View

18.

Yuan L, Yuan P, Yuan H, Wang Z, Run Z, Chen G . miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1. Am J Cancer Res. 2017; 7(1):159-172. PMC: 5250690. View

19.

Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S . miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer. 2014; 136(6):1308-20. DOI: 10.1002/ijc.29091. View

20.

Ambrosio S, Sacca C, Amente S, Paladino S, Lania L, Majello B . Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway. Oncogene. 2017; 36(48):6701-6711. PMC: 5717079. DOI: 10.1038/onc.2017.267. View